| | No. | Antibiotics | PR | GR |
| | 1 | Ampicillin (10 μg) | R | blaCTX-M-15 | | 2 | Amoxicillin/clavulanic acid (30 μg) | S | ND | | 3 | Piperacillin/tazobactam (40 μg) | S | ND | | 4 | Cefixime (5 μg) | R | TolC, H-NS, CTX-M-15, EC-5 | | 5 | Ceftriaxone (30 μg) | R | blaCTX-M-15 | | 6 | Ertapenem (10 μg) | S | marA, Escherichia coli soxS with mutation conferring antibiotic resistance | | 7 | Amikacin (30 μg) | S | aadA5 | | 8 | Gentamycin (10 μg) | S | aadA5 | | 9 | Nalidixic acid (30 μg) | R | TolC, evgA, H-NS, mdtM, gadW, emrR | | 10 | Ciprofloxacin (5 μg) | R | TolC, evgA, H-NS, mdtM, gadW, emrR | | 11 | Ofloxacin (5 μg) | R | TolC, evgA, H-NS, mdtM, gadW, emrR | | 12 | Fosfomycin (50 μg) | S | ND | | 13 | Nitrofurantoin (300 μg) | S | ND | | 14 | Sulfamethoxazole-trimethoprim (25 μg) | S | sul1, dfrA17, dfrA14 | | 15 | Aztreonam (30 μg) | S | marA, Escherichia coli soxS with mutation conferring antibiotic resistance | | 16 | Tetracycline | ND | tet(B) | | 17 | MLS (macrolide, lincosamide, and streptogramin B) | ND | mph(A) | | 18 | Disinfectant | ND | qacE |
|
|
